MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Apathy in Parkinson’s disease: serum biochemical markers and clinical features

    LT. Li, Y. Qu, HL. Gao, YJ. Xiong, Z. Min, ZJ. Mao, JY. Li, QX. Qin, DL. Wang, JW. Zhao, Z. Xue (Wuhan, China)

    Objective: This study aims to explore clinical features and blood biochemical markers of apathy in PD. Background: Apathy is one of the most common non-motor…
  • 2022 International Congress

    Impaired Imagery of Tremor in Patients with Essential Tremor

    K. Steidel, A R. Abou Watfa, C. Nelles, E. Pelzer, M. Tittgemeyer, L. Timmermann, DJ. Pedrosa (Marburg, Germany)

    Objective: To investigate neural mechanisms underlying motor imagination (MI) in essential tremor (ET) patients compared to healthy controls using high-density EEG. Background: ET ranges among…
  • 2022 International Congress

    Association between thyroid dysfunction and severity of depression in de novo patients with Parkinson’s disease

    I. Sarac, H. Sarac, N. Henigsberg, F. Borovecki, L. Bagaric Krakan, I. Ivek, M. Iveta, T. Sukobljevic, Z. Kresic (Zagreb, Croatia)

    Objective: This study aimed to evaluate the association between thyroid disturbances and severity of depression in de novo PD patients Croatian residents. Background: Thyroid disease…
  • 2022 International Congress

    PD+: A comprehensive, user-friendly mobile application for clinicians treating Parkinson’s Disease

    E. Shah, T. Khachatryan, N. Phielipp, S. Isfahani (Orange, USA)

    Objective: We developed a mobile application that converts dopaminergic medication dosages and calculates total Levodopa (L-dopa) equivalent daily dose (LEDD) in a Parkinson’s Disease (PD)…
  • 2022 International Congress

    Sex differences in vascular risk factors for Parkinson’s disease

    K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)

    Objective: Our aim is to illustrate the incidence of vascular risk factors (VRF) in a cohort of patients with confirmed Parkinson's disease (PD) and characterize…
  • 2022 International Congress

    Long non-coding RNAs in Parkinson’s disease: bringing back life to the grey matter?

    S. Acharya, A. Lumley, L. Zhang, V. Stopa, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to discover and delineate the role of novel long non-coding RNAs (lncRNAs) in Parkinson’s disease (PD). Background: LncRNAs have been widely…
  • 2022 International Congress

    Motor decision-making in Parkinson’s disease

    L. Avanzino, B. Berret, E. Pelosin, M. Bove, T. Pozzo, A. Bisio (Genoa, Italy)

    Objective: The aim of this study is to test motor decision-making ability in Parkinson's disease (PD) in conditions with different biomechanical properties and levels of…
  • 2022 International Congress

    A trail towards understanding cognitive impairment in PSP

    S. Kannenberg, A. Hausmann, C. Hartmann, J. Caspers, A. Schnitzler (Duesseldorf, Germany)

    Objective: To investigate cognitive impairment in 22 patients with Progressive Supranuclear Palsy with Richardson syndrome (PSP-RS). Background: PSP is a neurodegenerative disease and common differential…
  • 2022 International Congress

    The relationship of non-motor symptoms in Parkinson’s disease

    E. Golchenko, Y. Karakulova (Perm, Russian Federation)

    Objective:  Evaluation of non-motor symptoms in patients with Parkinson's disease, evaluation of the relationship of autonomic and neuropsychiatric disorders. Background: This work included a comprehensive…
  • 2022 International Congress

    Oscillatory activity of pause-burst STN neurons shows an association with motor symptoms of Parkinson’s disease

    E. Belova, V. Filyushkina, I. Dzhalagoniia, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: Here we aimed to investigate heterogeneity in the neuronal activity within the subthalamic nucleus (STN) to search the association between oscillatory activity and motor…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley